Ads
related to: large b-cell lymphoma- Prescribing Information
Prescribing Info For A 3L + Diffuse
Large B Cell Lymphoma Treatment.
- Safety Profile
View Important Safety Information
Including Boxed Warning.
- Prescribing Information
Search results
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment...
Benzinga· 2 days ago– Appointment adds strategic finance and broad operating experience to Board as Company advances potentially pivotal Phase 2 clinical study for CAR T-cell therapy candidate, firicabtagene autoleucel (firi-cel) – SAN
Newswise Expert | Cheryl London , Tufts University
Newswise· 1 day agoCheryl London, D.V.M., Ph.D., ACVIM, is the Anne Engen and Dusty Professor of Comparative Oncology and associate dean for research and graduate educati
H.C. Wainwright slashes Caribou Biosciences stock PT to $9 from $24 By Investing.com
Investing.com· 2 days agoCaribou Biosciences showcased findings from its CB-010 therapy, which demonstrated a 76.1% objective...
'Winner of the night': 4-year-old cancer survivor has his book set to music in unique performance
Milwaukee Journal Sentinel via Yahoo News· 2 days agoJames was rushed to the emergency room with such extreme abdominal pain he could not stand, his...
Phillies bat boy Adam Crognale beat childhood cancer. Now he spreads positivity in the dugout.
Philly.com· 6 days agoAdam Crognale used crutches to move from his hospital bed to the window while his mother rolled his...
Why US Drug Giant Bristol Myers Squibb Stock Trading Up On Monday - Bristol-Myers Squibb (NYSE:BMY)
Benzinga· 3 days agoAt a median follow-up of 9.4 months, Krazati demonstrated a statistically significant and clinically...
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with...
The Woonsocket Call· 5 days agoKaryopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced the presentation of updated exploratory subgroup analyses ...
Evercore ISI downgrades Caribou Biosciences stock amid strategic challenges By Investing.com
Investing.com· 3 days agoOn Monday, Evercore ISI adjusted its stance on Caribou Biosciences Inc. (NASDAQ:CRBU), downgrading...
Should You Buy the 3 Highest-Yielding Dividend Stocks in the Nasdaq-100? | The Motley Fool
The Motley Fool· 1 day agoNot included in these returns are the contributions of dividends. First up is Walgreens Boots...
Head-To-Head Survey: Ionis Pharmaceuticals (NASDAQ:IONS) versus Nurix Therapeutics (NASDAQ:NRIX)
ETF DAILY NEWS· 2 days agoNurix Therapeutics (NASDAQ:NRIX – Get Free Report) and Ionis Pharmaceuticals (NASDAQ:IONS – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two ...
Ads
related to: large b-cell lymphoma